In relapsing-remitting multiple sclerosis, activation of the peripheral immune system can lead to focal inflammation within the CNS. Over the past three decades, therapeutic development has been ...

The USA's Institute for Clinical and Economic Review (ICER) has released a Final Evidence Report assessing the comparative ...

The rates of people MS advancing from RRMS to SPMS have decreased significantly in the past decades, according to a 30-year ...

Mobility complications are often the first sign that relapsing-remitting multiple sclerosis (RRMS) is transitioning into secondary-progressive multiple sclerosis (SPMS). With this progression ...

Over time, symptoms of secondary progressive multiple sclerosis (MS) may affect your ability to walk. Learn about mobility devices for secondary progressive MS.

Secondary progressive multiple sclerosis (SPMS) can affect your ability to complete everyday tasks at work or home. Read on to learn more about how to make lifestyle adjustments to help manage ...

Imaging studies at the NIH Clinical Center showed that chronic active lesions with a paramagnetic rim exerted ongoing tissue ...

Tolebrutinib slows disability progression in adults with nonrelapsing secondary progressive multiple sclerosis (MS).

An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with their disorder, a new clinical trial suggests.

Cleveland Clinic-led trial is the first to show a delay in confirmed disability progression in non-relapsing secondary progressive multiple sclerosis ...

Relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults Primary progressive MS, in adults ...

Relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults Primary progressive MS, in adults ...